2022 American Transplant Congress
Post-Operative Day 1 Galectin-3 is Predictive of Early Allograft Dysfunction in Liver Transplantation
University of Colorado Anschutz Medical, Aurora, CO
*Purpose: Early allograft dysfunction (EAD) is an important outcome measure in liver transplantation that is predictive of graft failure, but the mechanism behind it remains…2022 American Transplant Congress
Pure Laparoscopic Donor Right Hepatectomy (PLDRH) – Can It be a Standardized, Reproducible and Cost Effective Procedure?
HPB and Liver Transplantation, AIG Hospitals, Hyderabad, India
*Purpose: Few centers in the world are doing PLDRH because of the long learning curve and donor safety concerns. Further longer operative time, difficulty in…2022 American Transplant Congress
The Role of Gut Microbiota in Tacrolimus Blood Level Fluctuation, Time in Therapeutic Range and AlloSure Donor Derived Cell-Free DNA, Controlling for CYP3A5
1George Mason University, Arlington, VA, 2George Washington University Hospital, Washington, DC
*Purpose: High tacrolimus variability (TV), low time in therapeutic range (TTR) and high percentage of donor derived cell-free DNA (dd-cfDNA) are associated with acute kidney…2022 American Transplant Congress
Impact of African American Race on Lcp-Tac Dosing and Clinical Outcomes
Medical University of South Carolina, Charleston, SC
*Purpose: The goal of this study was to assess the impact of African American (AA) race on the conversion ratio from Tac-IR to LCP-Tac, while…2022 American Transplant Congress
The Successful Use of De Novo Belatacept with Reduced Dose Tacrolimus to Mitigate the Risks of Delayed Graft Function in Kidney Transplantation
*Purpose: The new kidney allocation system has caused increased organ travel times and therefore increased cold ischemia time. Furthermore, the change in the priority to…2022 American Transplant Congress
The Impact of Obesity on Delayed Graft Function
1Royal Prince Alfred Hospital, Camperdown, Australia, 2University of Sydney, Camperdown, Australia
*Purpose: Obesity is increasingly prevalent among candidates for kidney transplantation. Outcomes for obese patients remain uncertain, as existing studies have shown conflicting short and longer-term…2022 American Transplant Congress
Transplant Patients Risk for SARS-CoV-2 Infection Post-2nd Vaccine Dose; We Are Not Home and Dry Yet
*Purpose: SARS-CoV-2 is associated with high mortality among transplant recipients. Data of transplant patients’ infections post-2nd vaccine dose is not available. The aim of the…2022 American Transplant Congress
Adverse Renal Events After BNT162b2 Pfizer/BioNTech COVID-19 Vaccine in Kidney Transplant Recipients
*Purpose: Adverse events of a novel mRNA vaccine are not well described in Kidney Transplant Recipients(KTR), especially the risk of immune activation or recurrent glomerulonephritis(GN),…2022 American Transplant Congress
Changes Of Socioeconomic Status Of Kidney Transplant Recipients And Their Association With Prognosis
*Purpose: Previous studies showed socioeconomic status affect the level of access to and prognosis of kidney transplantation. Further study is warranted to investigate the changes…2022 American Transplant Congress
Mycophenolate Mofetil-Related Diarrhea and Beta-Glucuronidase Activity Following Kidney Transplantation
*Purpose: The treatment of mycophenolate mofetil (MMF)-related diarrhea in kidney transplants recipients often involves dose reductions, which may result in less effective immunosuppression. We hypothesize…
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 190
- Next Page »